1
|
Parhi B, Bharatiya D, Swain SK. Application of quercetin flavonoid based hybrid nanocomposites: A review. Saudi Pharm J 2020; 28:1719-1732. [PMID: 33424263 PMCID: PMC7783214 DOI: 10.1016/j.jsps.2020.10.017] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2020] [Accepted: 10/31/2020] [Indexed: 12/18/2022] Open
Abstract
Natural bioflavonoids are an essential component of dietary supplements possessing antimicrobial properties. Many of the bioflavonoids have resulted in positive antitumor, anticancer, antibacterial, antifungal, anti-inflammatory properties, but the efficacy remains low due to toxicity at the molecular level whereas antiviral property limits to negative. The synergistic link between nanoscience and flavonoid chemistry enhances the epidemiological properties of flavonoid and also diminish the antimicrobial resistivity (AMR) by forming their hybrid nanocomposites. Nanochemistry uses various nanocomposite and nanomaterials for biosensing the flavonoids and their delivery as a drug. The quercetin flavonoid and its derivatives such as rutin, and myricetin are used for sensing and drug delivery. Quercetin with 15Carbon-5Hydroxyl chemical scaffold has been explored for a few decades for the development of hybrid nanocomposite and nanomaterial with metallic as well as organic nano co-composites. This quercetin flavonoid based hybrid nanocomposites seemed to show a significant effect on In vitro and some animal model processes along with attenuating lipid peroxidation, platelet aggregation, and capillary permeability actions. This review mainly focused on the hybrid nanoscience of quercetin bioflavonoid and its application in numerous biological, material fields with a future perspective.
Collapse
Affiliation(s)
- Biswajit Parhi
- Department of Chemistry, Veer Surendra Sai University of Technology, Burla, Sambalpur 768018, India
| | - Debasrita Bharatiya
- Department of Chemistry, Veer Surendra Sai University of Technology, Burla, Sambalpur 768018, India
| | - Sarat K Swain
- Department of Chemistry, Veer Surendra Sai University of Technology, Burla, Sambalpur 768018, India
| |
Collapse
|
2
|
When polymers meet carbon nanostructures: expanding horizons in cancer therapy. Future Med Chem 2020; 11:2205-2231. [PMID: 31538523 DOI: 10.4155/fmc-2018-0540] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The development of hybrid materials, which combine inorganic with organic materials, is receiving increasing attention by researchers. As a consequence of carbon nanostructures high chemical versatility, they exhibit enormous potential for new highly engineered multifunctional nanotherapeutic agents for cancer therapy. Whereas many groups are working on drug delivery systems for chemotherapy, the use of carbon nanohybrids for radiotherapy is rarely applied. Thus, nanotechnology offers a wide range of solutions to overcome the current obstacles of conventional chemo- and/or radiotherapies. Within this review, the structure and properties of carbon nanostructures (carbon nanotubes, nanographene oxide) functionalized preferentially with different types of polymers (synthetic, natural) are discussed. In short, synthesis approaches, toxicity investigations and anticancer efficacy of different carbon nanohybrids are described.
Collapse
|
3
|
Cirillo G, Vittorio O, Kunhardt D, Valli E, Voli F, Farfalla A, Curcio M, Spizzirri UG, Hampel S. Combining Carbon Nanotubes and Chitosan for the Vectorization of Methotrexate to Lung Cancer Cells. MATERIALS (BASEL, SWITZERLAND) 2019; 12:E2889. [PMID: 31500165 PMCID: PMC6766185 DOI: 10.3390/ma12182889] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 09/02/2019] [Accepted: 09/04/2019] [Indexed: 12/11/2022]
Abstract
A hybrid system composed of multi-walled carbon nanotubes coated with chitosan was proposed as a pH-responsive carrier for the vectorization of methotrexate to lung cancer. The effective coating of the carbon nanostructure by chitosan, quantified (20% by weight) by thermogravimetric analysis, was assessed by combined scanning and transmission electron microscopy, and X-ray photoelectron spectroscopy (N1s signal), respectively. Furthermore, Raman spectroscopy was used to characterize the interaction between polysaccharide and carbon counterparts. Methotrexate was physically loaded onto the nanohybrid and the release profiles showed a pH-responsive behavior with higher and faster release in acidic (pH 5.0) vs. neutral (pH 7.4) environments. Empty nanoparticles were found to be highly biocompatible in either healthy (MRC-5) or cancerous (H1299) cells, with the nanocarrier being effective in reducing the drug toxicity on MRC-5 while enhancing the anticancer activity on H1299.
Collapse
Affiliation(s)
- Giuseppe Cirillo
- Leibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany.
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
| | - Orazio Vittorio
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
- ARC Centre of Excellence for Convergent BioNano Science and Technology, Australian Centre for NanoMedicine, UNSW Sydney, NSW 2052, Australia.
- School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW 2052, Australia.
| | - David Kunhardt
- Leibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany.
| | - Emanuele Valli
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
- School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW 2052, Australia.
| | - Florida Voli
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
| | - Annafranca Farfalla
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
| | - Manuela Curcio
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
| | - Umile Gianfranco Spizzirri
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.
| | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany.
| |
Collapse
|
4
|
Lerra L, Farfalla A, Sanz B, Cirillo G, Vittorio O, Voli F, Le Grand M, Curcio M, Nicoletta FP, Dubrovska A, Hampel S, Iemma F, Goya GF. Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells. Pharmaceutics 2018; 11:E3. [PMID: 30583524 PMCID: PMC6359315 DOI: 10.3390/pharmaceutics11010003] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 12/14/2018] [Accepted: 12/18/2018] [Indexed: 01/18/2023] Open
Abstract
With the aim to obtain a site-specific doxorubicin (DOX) delivery in neuroblastoma SH-SY5Y cells, we designed an hybrid nanocarrier combining graphene oxide (GO) and magnetic iron oxide nanoparticles (MNPs), acting as core elements, and a curcumin⁻human serum albumin conjugate as functional coating. The nanohybrid, synthesized by redox reaction between the MNPs@GO system and albumin bioconjugate, consisted of MNPs@GO nanosheets homogeneously coated by the bioconjugate as verified by SEM investigations. Drug release experiments showed a pH-responsive behavior with higher release amounts in acidic (45% at pH 5.0) vs. neutral (28% at pH 7.4) environments. Cell internalization studies proved the presence of nanohybrid inside SH-SY5Y cytoplasm. The improved efficacy obtained in viability assays is given by the synergy of functional coating and MNPs constituting the nanohybrids: while curcumin moieties were able to keep low DOX cytotoxicity levels (at concentrations of 0.44⁻0.88 µM), the presence of MNPs allowed remote actuation on the nanohybrid by a magnetic field, increasing the dose delivered at the target site.
Collapse
Affiliation(s)
- Luigi Lerra
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
| | - Annafranca Farfalla
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| | - Beatriz Sanz
- nB nanoSacale Biomagnetics SL, 50012 Zaragoza, Spain.
| | - Giuseppe Cirillo
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| | - Orazio Vittorio
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
- ARC Centre of Excellence for Convergent BioNano Science and Technology, Australian Centre for NanoMedicine, UNSW Sydney, NSW 2052, Australia.
- School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW 2052, Australia.
| | - Florida Voli
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
| | - Marion Le Grand
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW 2031, Australia.
- ARC Centre of Excellence for Convergent BioNano Science and Technology, Australian Centre for NanoMedicine, UNSW Sydney, NSW 2052, Australia.
- School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW 2052, Australia.
| | - Manuela Curcio
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| | - Anna Dubrovska
- OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
- German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- German Cancer Consortium (DKTK), partner site Dresden, 01307 Dresden, Germany.
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-Oncoray, 01307 Dresden, Germany.
| | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden, 01069 Dresden, Germany.
| | - Francesca Iemma
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| | - Gerardo F Goya
- Institute of Nanoscience of Aragon (INA), Department of Condensed Matter Physics, University of Zaragoza, 50018 Zaragoza, Spain.
| |
Collapse
|
5
|
Ernest U, Chen HY, Xu MJ, Taghipour YD, Asad MHHB, Rahimi R, Murtaza G. Anti-Cancerous Potential of Polyphenol-Loaded Polymeric Nanotherapeutics. Molecules 2018; 23:molecules23112787. [PMID: 30373235 PMCID: PMC6278361 DOI: 10.3390/molecules23112787] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2018] [Revised: 10/04/2018] [Accepted: 10/12/2018] [Indexed: 12/14/2022] Open
Abstract
Recent evidence has extensively demonstrated the anticancer potential of nutraceuticals, including plant polyphenols. Polymeric nanocarrier systems have played an important role in improving the physicochemical and pharmacological properties of polyphenols, thus ameliorating their therapeutic effectiveness. This article summarizes the benefits and shortcomings of various polymeric systems developed for the delivery of polyphenols in cancer therapy and reveals some ideas for future work.
Collapse
Affiliation(s)
- Umeorah Ernest
- Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China.
| | - Hai-Yan Chen
- Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China.
| | - Ming-Jun Xu
- Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 210009, China.
| | - Yasamin Davatgaran Taghipour
- Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz 1416663547, Iran.
| | | | - Roja Rahimi
- Department of Traditional Pharmacy, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran 5165665931, Iran.
| | - Ghulam Murtaza
- Department of Pharmacy, COMSATS University Islamabad, Lahore Campus 54600, Pakistan.
| |
Collapse
|
6
|
Biagiotti G, Fedeli S, Tuci G, Luconi L, Giambastiani G, Brandi A, Pisaneschi F, Cicchi S, Paoli P. Combined therapies with nanostructured carbon materials: there is room still available at the bottom. J Mater Chem B 2018; 6:2022-2035. [PMID: 32254426 DOI: 10.1039/c8tb00121a] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The progress of the chemistry of carbon nanotubes (CNT) and graphene derivatives [mainly graphene oxide (GO)] has produced a number of technologically advanced drug delivery systems (DDS) that have been used in the field of nanomedicine, mostly in studies related to oncology. However, such a demanding field of research requires continuous improvements in terms of efficiency, selectivity and versatility. The loading of two, or more, bioactive components on the same nanoparticle offers new possibilities for treating cancer, efficiently addressing issues related both to biodistribution and pharmacokinetics. Nanostructured carbon materials (NCM), with their high surface area, their efficient cellular membrane crossing and their chemical versatility are ideal candidates for easy hetero-decoration and exploitation as advanced DDS. This review describes the achievements obtained in this area focusing on those studies in which two or more active components were loaded onto the DDS.
Collapse
Affiliation(s)
- Giacomo Biagiotti
- Department of Chemistry "Ugo Schiff", Università di Firenze, via della Lastruccia 3-13, 50019, Sesto Fiorentino, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Oliver S, Yee E, Kavallaris M, Vittorio O, Boyer C. Water Soluble Antioxidant Dextran–Quercetin Conjugate with Potential Anticancer Properties. Macromol Biosci 2018; 18:e1700239. [DOI: 10.1002/mabi.201700239] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Revised: 01/11/2018] [Indexed: 01/06/2023]
Affiliation(s)
- Susan Oliver
- Australian Centre for NanoMedicine (ACN) School of Chemical Engineering University of New South Wales Sydney 2052 Australia
- Centre for Advanced Macromolecular Design (CAMD) School of Chemical Engineering University of New South Wales Sydney 2052 Australia
| | - Eugene Yee
- Children's Cancer Institute Lowy Cancer Research Centre University of New South Wales Sydney 2052 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology Australian Centre for NanoMedicine (ACN) University of New South Wales Sydney 2052 Australia
| | - Maria Kavallaris
- Children's Cancer Institute Lowy Cancer Research Centre University of New South Wales Sydney 2052 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology Australian Centre for NanoMedicine (ACN) University of New South Wales Sydney 2052 Australia
| | - Orazio Vittorio
- Children's Cancer Institute Lowy Cancer Research Centre University of New South Wales Sydney 2052 Australia
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology Australian Centre for NanoMedicine (ACN) University of New South Wales Sydney 2052 Australia
| | - Cyrille Boyer
- Australian Centre for NanoMedicine (ACN) School of Chemical Engineering University of New South Wales Sydney 2052 Australia
- Centre for Advanced Macromolecular Design (CAMD) School of Chemical Engineering University of New South Wales Sydney 2052 Australia
| |
Collapse
|
8
|
Vittorio O, Le Grand M, Makharza SA, Curcio M, Tucci P, Iemma F, Nicoletta FP, Hampel S, Cirillo G. Doxorubicin synergism and resistance reversal in human neuroblastoma BE(2)C cell lines: An in vitro study with dextran-catechin nanohybrids. Eur J Pharm Biopharm 2017; 122:176-185. [PMID: 29129733 DOI: 10.1016/j.ejpb.2017.11.005] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Revised: 11/07/2017] [Accepted: 11/08/2017] [Indexed: 11/28/2022]
Abstract
Hybrid nanocarrier consisting in nanographene oxide coated by a dextran-catechin conjugate was proposed in the efforts to find more efficient Neuroblastoma treatment with Doxorubicin chemotherapy. The dextran-catechin conjugate was prepared by immobilized laccase catalysis and its peculiar reducing ability exploited for the synthesis of the hybrid carrier. Raman spectra and DSC thermograms were recorded to check the physicochemical properties of the nanohybrid, while DLS measurements, SEM, TEM, and AFM microscopy allowed the determination of its morphological and dimensional features. A pH dependent Doxorubicin release was observed, with 30 and 75% doxorubicin released at pH 7.4 and 5.0, respectively. Viability assays on parental BE(2)C and resistant BE(2)C/ADR cell lines proved that the high anticancer activity of dextran-catechin conjugate (IC50 19.9 ± 0.6 and 18.4 ± 0.7 µg mL-1) was retained upon formation of the nanohybrids (IC50 24.8 ± 0.7 and 22.9 ± 1 µg mL-1). Combination therapy showed a synergistic activity between doxorubicin and either bioconjugate or nanocarrier on BE(2)C. More interestingly, on BE(2)C/ADR we recorded both the reversion of doxorubicin resistance mechanism as a consequence of decreased P-gp expression (Western Blot analysis) and a synergistic effect on cell viability, confirming the proposed nanohybrid as a very promising starting point for further research in neuroblastoma treatment.
Collapse
Affiliation(s)
- Orazio Vittorio
- Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia; Australian Centre for NanoMedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales, NSW, Sydney, Australia
| | - Marion Le Grand
- Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia; Australian Centre for NanoMedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales, NSW, Sydney, Australia
| | - Sami A Makharza
- College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine
| | - Manuela Curcio
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy
| | - Paola Tucci
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy
| | - Francesca Iemma
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy
| | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden, 01171 Dresden, Germany
| | - Giuseppe Cirillo
- Department of Pharmacy Health and Nutritional Science, University of Calabria, 87036 Rende (CS), Italy.
| |
Collapse
|
9
|
A catechin nanoformulation inhibits WM266 melanoma cell proliferation, migration and associated neo-angiogenesis. Eur J Pharm Biopharm 2017; 114:1-10. [DOI: 10.1016/j.ejpb.2016.12.024] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 11/25/2016] [Accepted: 12/14/2016] [Indexed: 01/01/2023]
|
10
|
Vittorio O, Curcio M, Cojoc M, Goya GF, Hampel S, Iemma F, Dubrovska A, Cirillo G. Polyphenols delivery by polymeric materials: challenges in cancer treatment. Drug Deliv 2017; 24:162-180. [PMID: 28156178 PMCID: PMC8241076 DOI: 10.1080/10717544.2016.1236846] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Nanotechnology can offer different solutions for enhancing the therapeutic efficiency of polyphenols, a class of natural products widely explored for a potential applicability for the treatment of different diseases including cancer. While possessing interesting anticancer properties, polyphenols suffer from low stability and unfavorable pharmacokinetics, and thus suitable carriers are required when planning a therapeutic protocol. In the present review, an overview of the different strategies based on polymeric materials is presented, with the aim to highlight the strengths and the weaknesses of each approach and offer a platform of ideas for researchers working in the field.
Collapse
Affiliation(s)
- Orazio Vittorio
- a UNSW Australia, Children's Cancer Institute, Lowy Cancer Research Center and ARC Center of Excellence in Convergent Bio-Nano Science and Technology, Australian Center for NanoMedicine , Sydney , NSW , Australia
| | - Manuela Curcio
- b Department of Pharmacy Health and Nutritional Science , University of Calabria, Arcavacata di Rende , Italy
| | - Monica Cojoc
- c OncoRay-National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf , Dresden , Germany
| | - Gerardo F Goya
- d Institute of Nanoscience of Aragon (INA) and Department of Condensed Matter Physics, University of Zaragoza , Zaragoza , Spain
| | - Silke Hampel
- e Leibniz Institute of Solid State and Material Research Dresden , Dresden , Germany , and
| | - Francesca Iemma
- b Department of Pharmacy Health and Nutritional Science , University of Calabria, Arcavacata di Rende , Italy
| | - Anna Dubrovska
- c OncoRay-National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf , Dresden , Germany.,f German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) , Heidelberg , Germany
| | - Giuseppe Cirillo
- b Department of Pharmacy Health and Nutritional Science , University of Calabria, Arcavacata di Rende , Italy
| |
Collapse
|
11
|
Kunz-Schughart LA, Dubrovska A, Peitzsch C, Ewe A, Aigner A, Schellenburg S, Muders MH, Hampel S, Cirillo G, Iemma F, Tietze R, Alexiou C, Stephan H, Zarschler K, Vittorio O, Kavallaris M, Parak WJ, Mädler L, Pokhrel S. Nanoparticles for radiooncology: Mission, vision, challenges. Biomaterials 2016; 120:155-184. [PMID: 28063356 DOI: 10.1016/j.biomaterials.2016.12.010] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2016] [Revised: 12/08/2016] [Accepted: 12/09/2016] [Indexed: 12/29/2022]
Abstract
Cancer is one of the leading non-communicable diseases with highest mortality rates worldwide. About half of all cancer patients receive radiation treatment in the course of their disease. However, treatment outcome and curative potential of radiotherapy is often impeded by genetically and/or environmentally driven mechanisms of tumor radioresistance and normal tissue radiotoxicity. While nanomedicine-based tools for imaging, dosimetry and treatment are potential keys to the improvement of therapeutic efficacy and reducing side effects, radiotherapy is an established technique to eradicate the tumor cells. In order to progress the introduction of nanoparticles in radiooncology, due to the highly interdisciplinary nature, expertise in chemistry, radiobiology and translational research is needed. In this report recent insights and promising policies to design nanotechnology-based therapeutics for tumor radiosensitization will be discussed. An attempt is made to cover the entire field from preclinical development to clinical studies. Hence, this report illustrates (1) the radio- and tumor-biological rationales for combining nanostructures with radiotherapy, (2) tumor-site targeting strategies and mechanisms of cellular uptake, (3) biological response hypotheses for new nanomaterials of interest, and (4) challenges to translate the research findings into clinical trials.
Collapse
Affiliation(s)
- Leoni A Kunz-Schughart
- OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
| | - Anna Dubrovska
- OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
| | - Claudia Peitzsch
- OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
| | - Alexander Ewe
- Rudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, University of Leipzig, Germany
| | - Achim Aigner
- Rudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, University of Leipzig, Germany
| | - Samuel Schellenburg
- Institute of Pathology, University Hospital, Carl Gustav Carus, TU Dresden, Germany
| | - Michael H Muders
- Institute of Pathology, University Hospital, Carl Gustav Carus, TU Dresden, Germany
| | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden, 01171 Dresden, Germany
| | - Giuseppe Cirillo
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy
| | - Francesca Iemma
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy
| | - Rainer Tietze
- ENT-Department, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Professorship, University Hospital Erlangen, Erlangen, Germany
| | - Christoph Alexiou
- ENT-Department, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius Professorship, University Hospital Erlangen, Erlangen, Germany
| | - Holger Stephan
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01314 Dresden, Germany
| | - Kristof Zarschler
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01314 Dresden, Germany
| | - Orazio Vittorio
- Children's Cancer Institute Australia, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Australian Centre for NanoMedicine, Sydney, UNSW, Australia
| | - Maria Kavallaris
- Children's Cancer Institute Australia, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Australian Centre for NanoMedicine, Sydney, UNSW, Australia
| | - Wolfgang J Parak
- Fachbereich Physik, Philipps Universität Marburg, 35037 Marburg, Germany; CIC Biomagune, 20009 San Sebastian, Spain
| | - Lutz Mädler
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, 28359 Bremen, Germany
| | - Suman Pokhrel
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, 28359 Bremen, Germany.
| |
Collapse
|
12
|
Vittorio O, Cojoc M, Curcio M, Spizzirri UG, Hampel S, Nicoletta FP, Iemma F, Dubrovska A, Kavallaris M, Cirillo G. Polyphenol Conjugates by Immobilized Laccase: The Green Synthesis of Dextran-Catechin. MACROMOL CHEM PHYS 2016. [DOI: 10.1002/macp.201600046] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Affiliation(s)
- Orazio Vittorio
- Children's Cancer Institute Australia; Randwick 2031 NSW Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Australian Centre for NanoMedicine; UNSW Australia; Sydney 2052 NSW Australia
| | - Monica Cojoc
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus; Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstr. 74 01307 Dresden Germany
| | - Manuela Curcio
- Department of Pharmacy, Health and Nutritional Science; University of Calabria; Rende 87036 Italy
| | | | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden; 01171 Dresden Germany
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy, Health and Nutritional Science; University of Calabria; Rende 87036 Italy
| | - Francesca Iemma
- Department of Pharmacy, Health and Nutritional Science; University of Calabria; Rende 87036 Italy
| | - Anna Dubrovska
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus; Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstr. 74 01307 Dresden Germany
- German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ); 69120 Heidelberg Germany
| | - Maria Kavallaris
- Children's Cancer Institute Australia; Randwick 2031 NSW Australia
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Australian Centre for NanoMedicine; UNSW Australia; Sydney 2052 NSW Australia
| | - Giuseppe Cirillo
- Department of Pharmacy, Health and Nutritional Science; University of Calabria; Rende 87036 Italy
| |
Collapse
|
13
|
Spizzirri UG, Curcio M, Cirillo G, Picci N, Nicoletta FP, Iemma F. Functional hydrogels with a multicatalytic activity for bioremediation: Single-step preparation and characterization. J Appl Polym Sci 2016. [DOI: 10.1002/app.43338] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Umile Gianfranco Spizzirri
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| | - Manuela Curcio
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| | - Giuseppe Cirillo
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| | - Nevio Picci
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| | - Francesca Iemma
- Department of Pharmacy, Health and Nutritional Sciences; University of Calabria; I-87036 Rende (CS) Italy
| |
Collapse
|
14
|
Cheng R, Xue Y. Carbon Nanomaterials for Drug Delivery. SPRINGER SERIES IN BIOMATERIALS SCIENCE AND ENGINEERING 2016. [DOI: 10.1007/978-3-319-22861-7_2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
15
|
Oliver S, Thomas DS, Kavallaris M, Vittorio O, Boyer C. Efficient functionalisation of dextran-aldehyde with catechin: potential applications in the treatment of cancer. Polym Chem 2016. [DOI: 10.1039/c6py00228e] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Dextran aldehyde was functionalised with up to 38 wt% catechin and the resulting conjugate demonstrated cytotoxic efficacy against neuroblastoma cells.
Collapse
Affiliation(s)
- Susan Oliver
- Australian Centre for NanoMedicine (ACN)
- School of Chemical Engineering
- University of New South Wales
- Sydney
- Australia 2052
| | - Donald S. Thomas
- Nuclear Magnetic Resonance Facility
- Mark Wainwright Analytical Centre
- University of New South Wales
- Sydney
- Australia 2052
| | - Maria Kavallaris
- Children's Cancer Institute Australia
- Lowy Cancer Research Centre
- University of New South Wales
- Sydney
- Australia 2052
| | - Orazio Vittorio
- Children's Cancer Institute Australia
- Lowy Cancer Research Centre
- University of New South Wales
- Sydney
- Australia 2052
| | - Cyrille Boyer
- Australian Centre for NanoMedicine (ACN)
- School of Chemical Engineering
- University of New South Wales
- Sydney
- Australia 2052
| |
Collapse
|
16
|
Spizzirri UG, Curcio M, Cirillo G, Spataro T, Vittorio O, Picci N, Hampel S, Iemma F, Nicoletta FP. Recent Advances in the Synthesis and Biomedical Applications of Nanocomposite Hydrogels. Pharmaceutics 2015; 7:413-37. [PMID: 26473915 PMCID: PMC4695827 DOI: 10.3390/pharmaceutics7040413] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 09/07/2015] [Accepted: 09/30/2015] [Indexed: 12/05/2022] Open
Abstract
Hydrogels sensitive to electric current are usually made of polyelectrolytes and undergo erosion, swelling, de-swelling or bending in the presence of an applied electric field. The electrical conductivity of many polymeric materials used for the fabrication of biomedical devices is not high enough to achieve an effective modulation of the functional properties, and thus, the incorporation of conducting materials (e.g., carbon nanotubes and nanographene oxide) was proposed as a valuable approach to overcome this limitation. By coupling the biological and chemical features of both natural and synthetic polymers with the favourable properties of carbon nanostructures (e.g., cellular uptake, electromagnetic and magnetic behaviour), it is possible to produce highly versatile and effective nanocomposite materials. In the present review, the recent advances in the synthesis and biomedical applications of electro-responsive nanocomposite hydrogels are discussed.
Collapse
Affiliation(s)
| | - Manuela Curcio
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| | - Giuseppe Cirillo
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| | - Tania Spataro
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| | - Orazio Vittorio
- Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, 2052, Australia.
- Australian Centre for Nanomedicine, University of New South Wales, Sydney, 2052, Australia.
| | - Nevio Picci
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| | - Silke Hampel
- Leibniz Institute for Solid State and Materials Research, PF 270116, D-01171 Dresden, Germany.
| | - Francesca Iemma
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| | - Fiore Pasquale Nicoletta
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, I-87036 Rende, Italy.
| |
Collapse
|
17
|
Castro Nava A, Cojoc M, Peitzsch C, Cirillo G, Kurth I, Fuessel S, Erdmann K, Kunhardt D, Vittorio O, Hampel S, Dubrovska A. Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids. Int J Cancer 2015; 137:2492-503. [DOI: 10.1002/ijc.29614] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Revised: 04/17/2015] [Accepted: 04/30/2015] [Indexed: 12/14/2022]
Affiliation(s)
- Arturo Castro Nava
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstrasse 74 Dresden Germany
- Leibniz Institute of Solid State and Material Research Dresden; Dresden Germany
| | - Monica Cojoc
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstrasse 74 Dresden Germany
| | - Claudia Peitzsch
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstrasse 74 Dresden Germany
| | - Giuseppe Cirillo
- Department of Pharmacy; Health and Nutritional Sciences, University of Calabria; Arcavacata Di Rende Italy
| | - Ina Kurth
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstrasse 74 Dresden Germany
| | - Susanne Fuessel
- Department of Urology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden; Fetscherstrasse 74 Dresden Germany
| | - Kati Erdmann
- Department of Urology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden; Fetscherstrasse 74 Dresden Germany
| | - David Kunhardt
- Leibniz Institute of Solid State and Material Research Dresden; Dresden Germany
| | - Orazio Vittorio
- Children's Cancer Institute Australia Lowy Cancer Research Centre; UNSW Sydney Australia
- Australian Centre for NanoMedicine; University of New South Wales; Sydney NSW Australia
| | - Silke Hampel
- Leibniz Institute of Solid State and Material Research Dresden; Dresden Germany
| | - Anna Dubrovska
- OncoRay-National Center for Radiation Research in Oncology; Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf; Fetscherstrasse 74 Dresden Germany
- German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ); Heidelberg Germany
| |
Collapse
|
18
|
Curcio M, Spizzirri UG, Cirillo G, Vittorio O, Picci N, Nicoletta FP, Iemma F, Hampel S. On demand delivery of ionic drugs from electro-responsive CNT hybrid films. RSC Adv 2015. [DOI: 10.1039/c5ra05484b] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Electro responsive hybrid hydrogel films able to precisely modulate the release of drugs as a function of their net charge.
Collapse
Affiliation(s)
- M. Curcio
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - U. G. Spizzirri
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - G. Cirillo
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - O. Vittorio
- Children's Cancer Institute Australia
- Lowy Cancer Research Centre
- University of New South Wales
- Sydney
- Australia
| | - N. Picci
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - F. P. Nicoletta
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - F. Iemma
- Department of Pharmacy
- Health and Nutritional Sciences
- University of Calabria
- Rende (CS)
- Italy
| | - S. Hampel
- Leibniz Institute for Solid State and Materials Research
- Dresden
- Germany
| |
Collapse
|